NIH-funded research R01 grant

Understanding how genetic variants affect cellular function in a specific genetic disorder.

Official title: Cellular Phenotypes of Genetic Variants in Mucopolysaccharidosis

Funded at Washington University · NIH-11056725 · Data updated 2026-11-12

This study is looking at how certain genetic changes affect cells in people with Hunter syndrome, using new technology to help doctors understand if these changes are harmless or linked to the disease, which could lead to better diagnoses and treatment options for patients.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionWashington University
NIH-funded
Lab location1 site (Saint Louis, United States)
Project startApril 1, 2023
Project endMarch 31, 2028
Funding year2025
Award (this year)$450,047
NIH project number5R01NS132057-03
Project IDNIH-11056725 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Hunter syndrome or those with genetic variants of uncertain significance related to this condition.

Less likely to help

Patients with well-defined genetic disorders that are already understood and classified will likely not benefit from this research.

What this research studies

This research investigates the impact of genetic variants on cellular function, particularly focusing on Hunter syndrome. By utilizing a novel cell-based platform and machine learning, the study aims to evaluate the morphological characteristics of cells affected by these variants. This approach seeks to provide clearer insights into whether certain genetic changes are benign or disease-causing, which can help guide clinical decisions. Patients will benefit from improved diagnostic accuracy and better management strategies based on the functional assessment of their genetic variants.

Why it matters

Potential benefit: If successful, this research could lead to more accurate diagnoses and personalized treatment plans for patients with genetic disorders.

How similar studies have gone: Other research has shown promise in using cell-based assays and machine learning to assess genetic variants, indicating that this approach could be effective.

Where this research is happening

  • Washington University
    Saint Louis, United States
    Active

Researchers

  • Principal investigator: Dickson, Patricia I — Washington University
  • Study coordinator: Dickson, Patricia I

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.